It has been observed that several inflammatory biomarkers, that is, IL-1β, IL-4, IL-6, IL-10, TNF-α and C-reactive protein (CRP) are potential markers of increased risk of cardiovascular endpoints (Koenig 2013; Halcox et al. 2014), metabolic syndrome (Fuentes et al. 2013), lung (Guo et al. 2013) and colorectal cancer (CRC) (Wu et al. 2013; Song et al. 2013), and some other chronic diseases (Iyengar et al. 2013; Rodriguez-Hernandez et al. 2013). This evidence concerns the gene IL6 and colorectal carcinoma.